These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 24836182

  • 1. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
    Singh G, Sharma B, Jaggi AS, Singh N.
    Pharmacol Biochem Behav; 2014 Sep; 124():27-35. PubMed ID: 24836182
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.
    Sharma B, Singh N.
    Psychopharmacology (Berl); 2011 Jun; 215(4):677-87. PubMed ID: 21225418
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia.
    Kumar A, Kumar A, Jaggi AS, Singh N.
    Pharmacol Biochem Behav; 2015 Aug; 135():20-30. PubMed ID: 25987325
    [Abstract] [Full Text] [Related]

  • 4. Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.
    Sharma B, Singh N.
    Curr Neurovasc Res; 2010 Aug; 7(3):180-91. PubMed ID: 20560881
    [Abstract] [Full Text] [Related]

  • 5. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.
    Sharma B, Singh N.
    Pharmacol Biochem Behav; 2011 Dec; 100(2):320-9. PubMed ID: 21893084
    [Abstract] [Full Text] [Related]

  • 6. Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
    Jain S, Sharma B.
    Physiol Behav; 2016 Oct 01; 164(Pt A):140-50. PubMed ID: 27262216
    [Abstract] [Full Text] [Related]

  • 7. Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia.
    Aggarwal H, Gupta S, Sharma P, Sharma BM, Sharma B.
    Physiol Behav; 2022 May 15; 249():113767. PubMed ID: 35245527
    [Abstract] [Full Text] [Related]

  • 8. Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
    Singh M, Prakash A.
    Brain Res Bull; 2017 Jul 15; 133():31-41. PubMed ID: 28274813
    [Abstract] [Full Text] [Related]

  • 9. Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia.
    Kaur B, Singh N, Jaggi AS.
    Fundam Clin Pharmacol; 2009 Oct 15; 23(5):557-66. PubMed ID: 19656209
    [Abstract] [Full Text] [Related]

  • 10. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
    Sharma B, Singh N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):207-15. PubMed ID: 22510463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
    Singh P, Gupta S, Sharma B.
    Curr Neurovasc Res; 2016 Aug 07; 13(3):219-29. PubMed ID: 27189349
    [Abstract] [Full Text] [Related]

  • 14. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
    Iglarz M, Steiner P, Wanner D, Rey M, Hess P, Clozel M.
    J Cardiovasc Pharmacol; 2015 Oct 07; 66(4):332-7. PubMed ID: 25992919
    [Abstract] [Full Text] [Related]

  • 15. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
    Sharma B, Singh N, Singh M.
    J Psychopharmacol; 2008 Mar 07; 22(2):162-71. PubMed ID: 18208924
    [Abstract] [Full Text] [Related]

  • 16. Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes.
    Said SA, Ammar el SM, Suddek GM.
    Pharmacol Res; 2005 Feb 07; 51(2):107-15. PubMed ID: 15629255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice.
    Tota S, Awasthi H, Kamat PK, Nath C, Hanif K.
    Behav Brain Res; 2010 May 01; 209(1):73-9. PubMed ID: 20096732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.